Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients.

Tanay Kaymak, Federico Moriconi,Jan H Niess,Christoph Beglinger,Petr Hruz

Inflammatory intestinal diseases（2018）

引用 7|浏览7

暂无评分

摘要

A low discontinuation rate was observed for steroid-dependent/refractory moderate to severe CD patients with IFX treatment. As FC showed a more or less pronounced decrease depending on the response to the IFX treatment, monitoring of FC may become a noninvasive tool for tailoring biological therapy in CD patients.

查看译文

关键词

Crohn's disease,Fecal calprotectin,Infliximab,Relapse,Remission

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要